e-ISSN: Pending
Failed Experiment ReportOpen accessDiseases of the blood and blood-forming organs

Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia Report

Pedro Henrique Prata; Dirk-Jan Eikema; Brian Piepenbroek; Austin Kulasekararaj; Beatrice Drexler; Jennifer M-L. Tjon; Krista Vaht; Mahmoud Aljurf · 2025 · Haematologica

WASTE classifies this as Failed Experiment Report · AI classification, approximate

An experimental approach did not work as intended — learn what to avoid before investing the same effort.

Abstract

Aplastic anemia (AA) transformation into myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) is associated with a dismal prognosis. Hematopoietic stem cell transplant offers the sole possibility of cure, but data on long-term survival are scarce. We retrospectively analyzed 270 patients transplanted for MDS, AML, or an isolated cytogenetic abnormality after a diagnosis of AA or paroxysmal nocturnal hemoglobinuria reported to the EBMT. The median age at transplantation was 39 years. The 5-year overall survival (OS) rate was 64%, unaffected by chromosome 7 abnormalities, age at trans

Abstract by Pedro Henrique Prata; Dirk-Jan Eikema; Brian Piepenbroek; Austin Kulasekararaj; Beatrice Drexler; Jennifer M-L. Tjon; Krista Vaht; Mahmoud Aljurf, Haematologica (2025) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: DOAJ · DOI 10.3324/haematol.2024.287205